US equities |
MU $1,088.00 ▲+4.06% NVDA $237.47 ▼-0.74% SNDK $1,692.42 ▲+1.92% SPCX $167.60 ▼-2.51% AMD $645.86 ▼-0.55% AAPL $336.67 ▲+0.91% TSLA $377.81 ▼-0.75% META $721.31 ▼-2.38%
FinancialContent

Latest News about Vitiligo

Recent news which mentions Vitiligo

Incyte's Topical JAK Inhibitor Under Priority FDA Review For Depigmented Skin Disorder
Tickers INCY
Tags Market News Health Care Biotech
From Benzinga
FDA Approves AVITA Medical Vitiligo Trial With Fewer Participants
Tickers RCEL
Tags Health Care Market News Small Cap
From Benzinga